Sydenham Chorea.

What is Sydenham chorea?

Sydenham chorea is the classic neurologic manifestation of acute rheumatic fever. It is caused by immune cross-reactivity after Group A streptococcal infection, with antibodies that target basal ganglia structures in the brain. It is a recognized major manifestation in the Jones criteria for rheumatic fever and remains clinically important, particularly in pediatric patients.

Sydenham chorea also supports the broader concept that Group A streptococcal infection can produce immune-mediated neuropsychiatric disease — an idea that informs the modern PANDAS framework as well.

Historical context and modern relevance

Historically known as chorea minor or St. Vitus' dance, Sydenham chorea was once one of the most recognizable pediatric movement disorders. With improved diagnosis and treatment of streptococcal infection in many high-resource settings, it is less common than it once was — but it is still clinically important and is sometimes missed when the connection to a preceding strep infection is not recognized. In some regions, particularly globally, Sydenham chorea and acute rheumatic fever remain common.

Symptoms

Reported features include:

• Involuntary, purposeless movements, often most prominent in the hands and face
• Motor incoordination and weakness
• Handwriting deterioration
• Slurred or hypotonic speech
• Emotional lability and anxiety
• Obsessive-compulsive symptoms
• Behavioral change — irritability, withdrawal, attention problems
• Symptoms may appear weeks after the index streptococcal infection, sometimes after the throat symptoms have resolved

How Dr. McNeil approaches evaluation

Evaluation is individualized but typically includes:

• A detailed history including any prior or recent streptococcal infection
• Streptococcal antibody titers (ASO, anti-DNase B)
• Inflammatory markers as appropriate
• Cardiac evaluation including echocardiogram when rheumatic fever is being considered — carditis is the most clinically significant manifestation of rheumatic fever, and missing it has consequences
• Neurologic evaluation, with coordination with pediatric or adult neurology as appropriate
• Standard immune workup where it adds value
• Coordination with cardiology, neurology, rheumatology, pediatrics, and primary care

Treatment approach

Treatment is individualized and is anchored in the rheumatic fever framework when criteria are met. Components may include:

• Antibiotic treatment of any confirmed ongoing streptococcal infection
• Secondary prophylaxis to prevent recurrent Group A streptococcal exposure, per AHA guidelines, when criteria are met
• Symptomatic neurologic treatment through neurology when needed
• Selected immunomodulatory therapy in severe or refractory cases when appropriate
• Cardiology follow-up as appropriate when rheumatic fever is confirmed

IVIG and other immunotherapies are reserved for selected severe or refractory cases when criteria are met — they are not routine.

Insurance and prior authorization

Dr. McNeil does not accept blanket insurance denials when the medical record supports treatment. For qualified patients, the team pursues the available authorization pathways — including written appeals, peer-to-peer discussions with insurance medical directors, and formal prior authorization review. Some carriers make this process harder than others. The practice continues to advocate for medically appropriate treatment regardless of insurance type.

To be clear: evaluation does not guarantee a diagnosis, and a diagnosis does not guarantee insurance approval for any specific therapy. Treatment decisions are individualized based on clinical findings and supported by objective documentation. Where treatment is appropriate, the team works hard on the patient's behalf.

Treatment pathway at Optimed Immunology

Every patient’s situation is different, but the decision logic for Sydenham chorea generally follows these steps. This is not a script — it is a structure that gets adapted to each patient’s history, findings, and goals.